In:
Cancer, Wiley, Vol. 97, No. 8 ( 2003-04-15), p. 1985-1990
Abstract:
Twenty‐three patients with advanced cancer were accrued to 3 dose levels of tezacitabine (150–270 mg/m 2 ) and cisplatin (50 mg/m 2 ). Hematologic toxicity was dose limiting and two patients with upper gastrointestinal malignancies had partial responses.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2003
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1